Submitted by Anonymous (not verified) on 24 June 2025 - 17:04
Opinion/decision on a Paediatric investigation plan (PIP): Vanflyta, Quizartinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts and polyps), PIP number: P/0203/2024
Source: